# Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet

> **NCT04651088** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Kidney Stone

## Interventions

- **DRUG:** Potassium citrate
- **DRUG:** Sodium bicarbonate
- **DIETARY_SUPPLEMENT:** Litholyte
- **DIETARY_SUPPLEMENT:** Crystal Lite
- **DRUG:** Potassium Bicarbonate

## Key facts

- **NCT ID:** NCT04651088
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-07
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651088, "Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04651088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*